These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
697 related items for PubMed ID: 22407922
1. Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival. Mannoor K, Matejuk A, Xu Y, Beardall M, Chen C. J Immunol; 2012 Apr 15; 188(8):3628-38. PubMed ID: 22407922 [Abstract] [Full Text] [Related]
2. Piperlongumine alleviates lupus nephritis in MRL-Fas(lpr) mice by regulating the frequency of Th17 and regulatory T cells. Yao L, Chen HP, Ma Q. Immunol Lett; 2014 Sep 15; 161(1):76-80. PubMed ID: 24837470 [Abstract] [Full Text] [Related]
3. CXCR3 promotes the production of IgG1 autoantibodies but is not essential for the development of lupus nephritis in NZB/NZW mice. Moser K, Kalies K, Szyska M, Humrich JY, Amann K, Manz RA. Arthritis Rheum; 2012 Apr 15; 64(4):1237-46. PubMed ID: 22006377 [Abstract] [Full Text] [Related]
9. Control of spontaneous B lymphocyte autoimmunity with adenovirus-encoded soluble TACI. Liu W, Szalai A, Zhao L, Liu D, Martin F, Kimberly RP, Zhou T, Carter RH. Arthritis Rheum; 2004 Jun 15; 50(6):1884-96. PubMed ID: 15188365 [Abstract] [Full Text] [Related]
10. Correlation of renal tubular epithelial cell-derived interleukin-18 up-regulation with disease activity in MRL-Faslpr mice with autoimmune lupus nephritis. Faust J, Menke J, Kriegsmann J, Kelley VR, Mayet WJ, Galle PR, Schwarting A. Arthritis Rheum; 2002 Nov 15; 46(11):3083-95. PubMed ID: 12428253 [Abstract] [Full Text] [Related]
11. Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice. Anders HJ, Vielhauer V, Eis V, Linde Y, Kretzler M, Perez de Lema G, Strutz F, Bauer S, Rutz M, Wagner H, Gröne HJ, Schlöndorff D. FASEB J; 2004 Mar 15; 18(3):534-6. PubMed ID: 14734643 [Abstract] [Full Text] [Related]
12. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice. Yasuda T, Yoshimoto T, Tsubura A, Matsuzawa A. Cell Immunol; 2001 Jun 15; 210(2):77-86. PubMed ID: 11520074 [Abstract] [Full Text] [Related]
13. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice. Pérez de Lema G, Maier H, Franz TJ, Escribese M, Chilla S, Segerer S, Camarasa N, Schmid H, Banas B, Kalaydjiev S, Busch DH, Pfeffer K, Mampaso F, Schlöndorff D, Luckow B. J Am Soc Nephrol; 2005 Dec 15; 16(12):3592-601. PubMed ID: 16267157 [Abstract] [Full Text] [Related]
14. Role of the costimulatory molecule CD28 in the development of lupus in MRL/lpr mice. Tada Y, Nagasawa K, Ho A, Morito F, Koarada S, Ushiyama O, Suzuki N, Ohta A, Mak TW. J Immunol; 1999 Sep 15; 163(6):3153-9. PubMed ID: 10477582 [Abstract] [Full Text] [Related]
15. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis. Steinmetz OM, Turner JE, Paust HJ, Lindner M, Peters A, Heiss K, Velden J, Hopfer H, Fehr S, Krieger T, Meyer-Schwesinger C, Meyer TN, Helmchen U, Mittrücker HW, Stahl RA, Panzer U. J Immunol; 2009 Oct 01; 183(7):4693-704. PubMed ID: 19734217 [Abstract] [Full Text] [Related]
16. Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice. Matsumoto K, Watanabe N, Akikusa B, Kurasawa K, Matsumura R, Saito Y, Iwamoto I, Saito T. Arthritis Rheum; 2003 Feb 01; 48(2):486-94. PubMed ID: 12571859 [Abstract] [Full Text] [Related]
17. Autoantibody responses and pathology regulated by B7-1 and B7-2 costimulation in MRL/lpr lupus. Liang B, Kashgarian MJ, Sharpe AH, Mamula MJ. J Immunol; 2000 Sep 15; 165(6):3436-43. PubMed ID: 10975864 [Abstract] [Full Text] [Related]